Heparanase: A Novel Therapeutic Target for the Treatment of Atherosclerosis

Area of Science:

• Biochemistry
• Molecular Biology
• Cardiovascular Research

Background:

• Cardiovascular disease (CVD) is a leading global cause of mortality, with atherosclerosis being a primary contributor.
• Atherosclerosis involves chronic arterial wall inflammation and lipid-rich plaque formation, necessitating a deeper understanding of its mechanisms.
• Heparanase is an enzyme that degrades heparan sulfate, a critical component of the extracellular matrix and basement membranes.

Purpose of the Study:

• To review the physiological and pathological roles of heparanase.
• To focus on the emerging involvement of heparanase in the development and progression of atherosclerosis.
• To highlight the need for detailed mechanistic understanding for improved CVD treatment and prevention.

Main Methods:

• Literature review of existing research on heparanase.
• Analysis of heparanase's role in extracellular matrix regulation.
• Synthesis of evidence linking heparanase to inflammatory processes in atherosclerosis.
• Examination of heparanase's impact on atherosclerotic plaque stability.

Main Results:

• Heparanase regulates numerous physiological and pathological processes, including inflammation and cell migration.
• Emerging evidence indicates heparanase has a multifaceted role in atherosclerosis.
• Heparanase promotes inflammation, contributing to atherosclerotic plaque formation.
• The enzyme also influences the stability of atherosclerotic lesions.

Conclusions:

• Heparanase is implicated in the inflammatory pathways underlying atherosclerosis.
• The enzyme's dual role in plaque formation and stability makes it a significant factor in CVD.
• Further research into heparanase mechanisms is essential for novel therapeutic strategies against atherosclerosis.